Company news

InspireMD Inc. news in 2020

InspireMD Inc.'s news releases, calls and decks from 2020, newest first.

View company

InspireMD Announces Third Quarter 2020 Financial Results

November 8, 2020

InspireMD, Inc. Appoints Andrea Tommasoli Senior Vice President of Global Sales and Marketing and Reports Inducement Grants Under NYSE American Company Guide §711(a)

November 2, 2020

InspireMD to Report Third Quarter 2020 Financial Results on Monday, November 9, 2020 and Provide Corporate Update

November 1, 2020

InspireMD Announces Renowned Interventional Cardiologist Gary S. Roubin, M.D., Ph.D., to Join Board of Directors

October 12, 2020

InspireMD, Inc. Appoints Patrick Jamnik as Vice President of Business Development and Strategic Initiatives and Reports Inducement Grants Under NYSE American Company Guide §711(a)

October 5, 2020

InspireMD Announces Christina Brennan, M.D., MBA to Serve in Advisory Role for Pivotal Study of CGuard Carotid Stent System

September 9, 2020

InspireMD Announces Approval of Investigational Device Exemption (IDE) for Pivotal Study of CGuard Carotid Stent System

September 7, 2020

InspireMD Announces the European Society of Cardiology 2020 “Best Poster Award” for Updated Data from the PARADIGM-EXTEND Study

September 2, 2020

InspireMD Regains Compliance with NYSE AMERICAN Listing Standards

August 9, 2020

InspireMD Announces Second Quarter 2020 Financial Results

August 4, 2020

InspireMD to Report Second Quarter 2020 Financial Results on Wednesday, August 5, 2020 and Provide Corporate Update

July 27, 2020

InspireMD Gains Registration Clearance of its CGuard™ Embolic Prevention System (EPS) in Brazil

July 22, 2020

InspireMD Announces Late-Breaking Presentation of Early SIBERIA Clinical Trial Results to be Featured in an e-Course at EuroPCR

June 24, 2020

InspireMD Announces Publication of 12-Month Results of CGuard™ EPS PARADIGM Trial in EuroIntervention

June 9, 2020

InspireMD, Inc. Announces Underwriter Exercise of Over-Allotment Option in Full and Closing of $11.5 Million Follow-On Underwritten Public Offering

June 7, 2020

InspireMD, Inc. Announces Pricing of $10 Million Underwritten Public Offering

June 2, 2020

InspireMD Announces First Quarter 2020 Financial Results

May 11, 2020

InspireMD to Report First Quarter 2020 Financial Results and Provide Business Update on Tuesday, May 12

May 4, 2020

InspireMD Announces Fourth Quarter and Year-End 2019 Financial Results

March 9, 2020

InspireMD to Report Fourth Quarter 2019 Financial Results and Provide Business Update on Tuesday, March 10

March 2, 2020

InspireMD Announces Successful Live Clinical Case Transmissions Featuring CGuard™ EPS at the Leipzig Interventional Course (LINC) 2020

January 28, 2020

InspireMD’s CGuard™ Embolic Prevention System to be Prominently Featured in Live Case Transmission at LINC, 28th to the 31st January 2020, in Leipzig, Germany

January 26, 2020

InspireMD Announces Strong Preliminary Fourth Quarter 2019 Revenue and Reports Inducement Award Under NYSE American Company Guide §711(a)

January 5, 2020

Calls in 2020

Decks in 2020